Identification of a role for NF-κB2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii

Journal of Immunology

Volumn 165, Issue 10, 2000, Pages 5720-5728

  Caamano, J ^a   Tato, C ^a   Cai, G ^a   Villegas, E N ^a   Speirs, K ^a   Craig, L ^a   Alexander, J ^a   Hunter, C A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELLULAR IMMUNITY; CHRONICITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENCEPHALITIS; FEMALE; INFECTION RESISTANCE; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; TOXOPLASMA GONDII;

EID: 0034669923     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.10.5720     Document Type: Article

References (73)

1. Structure, regulation and function of NF-κB
2. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
3. The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation
4. Signal transduction through NF-κB
5. Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes
6. Sensitization of human umbilical vein endothelial cells to shiga toxin: Involvement of protein kinase C and NF-κB
7. Regulation of nuclear factor-κB and its inhibitor IκB-α/MAD-3 in monocytes by Mycobacterium tuberculosis and during human tuberculosis
8. Borrelia burgdorferi activates nuclear factor-κB and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts
9. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase
10. In vivo inhibition of nuclear factor-κB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock
11. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation
12. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen
13. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor
14. Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-κB
15. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
16. The Rel subunit of NF-κB-like transcription factors is a positive and negative regulator of macrophage gene expression: Distinct roles for Rel in different macrophage populations
17. Multifocal defects in immune responses in RelB-deficient mice
18. Immunological defects in mice with a targeted disruption in Bcl-3
19. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic architecture, and germinal center reactions
20. Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture
21. 2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses
22. Mice lacking the transcription factor subunit rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response
23. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome
24. Toxoplasmosis in patients with cancer
25. Necrotizing toxoplasmic encephalitis in a child with the X-linked hyper-IgM syndrome
26. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection
27. Induction of interleukin-12 p40 transcript by CD40 ligation via activation of nuclear factor-κB
28. Expression of relB is required for the development of thymic medulla and dendritic cells
29. Mutiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family
30. + dendritic cells
31. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas
32. Interaction of NF-κB and NFAT with the interferon-promoter
33. Costimulation reverses the defect in IL-2 but not effector cytokine production by T cells with impaired IκBα degradation
34. In vivo inhibition of NF-κB in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis
35. The NF-κB family member RelB is required for innate and adaptive immunity to Toxoplasma gondii
36. Microbiostatic effect of murine activated macrophages for Toxoplasma gondii: Role for synthesis of inorganic nitrogen oxides from L-arginine
37. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii
38. Western blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies
39. Immunohistological study of the anatomic relationship of Toxoplasma antigens to the inflammatory response in the brains of mice chronically infected with Toxoplasma gondii
40. The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii
41. Strategies of anti-cytokine monoclonal antibody development: Immunoassay of IL-10 and IL-5 in clinical samples
42. Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen
43. Roles of γ interferon and other cytokines in suppression of the spleen cell proliferative response to concanavlin A and Toxoplasma antigen during acute toxoplasmosis
44. Production of γ interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: Regulation by interleukin-10, interleukin-12, and tumor necrosis factor α
45. In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection
46. B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii
47. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-γ, TNF-α, and inducible nitric oxide synthase
48. Toxoplasma gondii infection in marrow transplant recipients: A 20 year experience
49. IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival
50. Stimulus-dependent synergism of the antiapoptotic tumor necrosis factor receptor-associated factor 2 (TRAF2) and nuclear factor κB pathways
51. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
52. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis
53. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis
54. Role of NF-κB in p53-mediated programmed cell death
55. A critical role for the RelA subunit of nuclear factor κB in regulation of multiple immune-response genes and in Fas-induced cell death
56. Apoptosis-resistant T cells have a deficiency in NF-κB-mediated induction of Fas ligand transcription
57. NF-κB-dependent Fas ligand expression
58. Regulation of Fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor κB
59. Distinct activities of p52/NF-κB required for proper secondary lymphoid organ microarchitecture: Functions enhanced by Bcl-3
60. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis
61. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
62. Functional responses and apoptosis of CD25 (IL-2Rα)-deficient T cells expressing a transgenic antigen
63. Regulation of Fas-dependent activation-induced T cell apoptosis by cAMP signaling: A potential role for transcription factor NF-κB
64. Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-κB
65. Inhibition of nuclear factor κB activation attenuates apoptosis resistance in lymphoid cells
66. Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression
67. Regulation of apoptosis in the immune system
68. The duration of antigenic stimulation determines the fate of naive and effector T cells
69. Differential ability of T cell subsets to undergo activation-induced cell death
70. HIV-induced immunopathogenesis
71. Programmed cell death in peripheral lymphocytes from HIV-infected persons: Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression
72. Chronic activation of the immune system in HIV infection: Contribution to T cell apoptosis and Vβ selective T cell anergy
73. + T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis